ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist I at Generate:Biomedicines - ApplyBlast

Senior Scientist I

Generate:Biomedicines

9 days ago

4.0 on Glassdoor

Somerville, Massachusetts, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Generate Biomedicines is seeking a Senior Scientist I to join the Protein Analytics & Biophysics team, leading analytical characterization and biophysical workflows to assess protein quality and stability. The role involves hands-on execution of separation science, binding analyses, and mass spectrometry to support discovery programs and the company's machine learning-powered platform. This position requires strong scientific judgment and collaboration across cross-functional teams to advance methods and troubleshoot complex experiments.

Responsibilities

Lead analytical and biophysical workflows to assess protein stability and developability
Develop and optimize separation workflows including chromatography and capillary electrophoresis
Perform binding analyses using SPR and contribute to mass spectrometry characterization workflows

Skills

Qualifications

Ph.D. in biochemistry, biophysics, analytical chemistry, protein science, or a related disciplineM.S. with 8+ years of relevant experience

About Generate:Biomedicines

generatebiomedicines.com

Headquarters

Somerville, Massachusetts, United States

Company Size

201-500 employees

View Profile

Generate:Biomedicines is a therapeutics company that combines machine learning, computational biology, and biological engineering to design and develop precision protein medicines and antibodies. Using generative AI and lab-driven engineering, the company builds targeted biologics and epitope-focused candidates, advancing a pipeline from discovery through clinical development. Its clinical-stage programs include GB-0895, a long‑acting anti‑TSLP antibody progressing to global Phase 3 studies, and the company has recently completed an initial public offering. Generate was incubated by Flagship Pioneering and emphasizes platform-driven discovery to accelerate novel biologic therapeutics.